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Abstract 
Background: Around a quarter of people post stroke will experience aphasia, a language disability. 
Having aphasia places someone at risk of becoming depressed and isolated. There is limited 
evidence for effective interventions to enhance psychological well-being for this client group. A 
potential intervention is Solution Focused Brief Therapy (SFBT), which supports a person to build 
meaningful, achievable change through focusing on a person’s skills and resources rather than their 
deficits. The SOFIA Trial aims to explore the acceptability of SFBT to people with varying 
presentations of aphasia, including severe aphasia, and to assess the feasibility of conducting a 
future definitive trial investigating clinical and cost effectiveness.  
Methods: The trial is a single-blind, randomised, wait-list controlled feasibility trial with nested 
qualitative research and pilot economic evaluation comparing SFBT plus usual care to usual care 
alone. The study will recruit 32 participants with aphasia who are ≥6 months post stroke. All 
participants will be assessed on psychosocial outcome measures at baseline, then at three and six 
months post randomisation by assessors blinded to treatment allocation. Participants will be 
randomly assigned to intervention group (start intervention immediately post randomisation) or 
wait-list group (start intervention six months post randomisation). Wait-list group will additionally be 
assessed nine months post randomisation. The intervention consists of up to six SFBT sessions 
delivered over three months by speech and language therapists. Participants and therapists will also 
take part in in-depth interviews exploring their experiences of the study. The pilot economic 
evaluation will use the EQ-5D-5L measure and an adapted Client Service Receipt Inventory. People 
with aphasia have been involved in designing and monitoring the trial. 
Discussion: Given the high levels of depression and isolation, there is a need to investigate effective 
interventions that enhance the psychological wellbeing of people with aphasia.  
Trial registration: ClinicalTrials.gov NCT03245060. 10/08/2017.  
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Introduction 
Aphasia occurs following brain damage and can affect a person’s ability to talk, understand, read or 
write. There are 110,000 strokes each year in England [1]. Around 45% of people will experience 
aphasia immediately post stroke; by three months, the aphasia persists for 24% of the stroke 
population [2]. It is estimated that for 15% of people post stroke the aphasia will be a life-long 
condition [3]. The impact of losing language skills on a person’s identity and well-being can be 
considerable. Those with aphasia are disproportionately likely to lose contact with friends [4, 5], and 
have weaker social networks [6] than those without aphasia. Further, rates of depression post stroke 
are high for people with aphasia with one study finding that 70% of people with aphasia at 3 months 
and 62% at 12 months post stroke fulfilled the DSM-III-R criteria for depression [7]. Expressive 
communication impairment has also been found to be a significant predictor of depression at one 
and six months post stroke [8].  
There has been increasing recognition of the need to consider the psychological consequences of 
long-term health conditions [9]. Stroke service guidelines in the UK state that ‘psychological care for 
this group [people post stroke] is as essential as physical rehabilitation’ [10]. Yet the UK Stroke 
Association reported that two thirds of stroke survivors felt their emotional needs were not as well 
addressed as their physical needs [11]. Services addressing longer-term psychological well-being 
post stroke have been identified as particularly weak [1]. A study exploring the views of UK speech 
and language therapists found that people with aphasia were observed to be at risk of not receiving 
appropriate psychological support. In part this was due to mental health professionals finding it 
difficult to deliver care due to the communication difficulties. Conversely although speech and 
language therapists were able to facilitate communication they often lacked the necessary support 
or training to feel confident addressing psychological needs [12, 13]. There was particular concern 
about people with more severe aphasia accessing mental health support [13].  
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Most studies exploring effective psychological interventions post stroke exclude people with aphasia 
[14], and a systematic review of interventions to prevent and treat depression in post-stroke aphasia 
found only limited evidence [15]. The only randomised controlled trial reporting significant benefit 
when treating low mood in people with aphasia was the Communication and Low Mood (CALM) 
study [16] where behavioural activation therapy was delivered by assistant psychologists.  
While severe or persistent mood disorders require specialist input from mental health professionals 
[17], there has been increasing recognition that psychological care is the concern of the whole 
healthcare team [18]. UK health service guidelines suggest that mild/moderate symptoms of 
depression, commonly experienced post stroke, may be addressed by non-psychology stroke 
specialist staff with support from clinical psychologists [17]. In two surveys of aphasia-specialist 
Speech and language therapists the vast majority (98% in Australia [19]; 93% in UK [12]) agreed that 
addressing the psychological needs of their clients was a part of their role. However, only a minority 
(31% in Australia [19]; 42% in UK [12]) reported that they felt confident to do so. There is currently a 
lack of research evaluating an intervention for mild/moderate depression which may enhance 
psychological well-being delivered by Speech and language therapists with appropriate support.  
One potential psychological intervention is Solution Focused Brief Therapy (SFBT) which is a client-
centred resource-based therapy that aims to enable people to build change in their everyday lives 
[20, 21]. It explores a person’s hopes, how they would like their life to be, and builds on what is 
already working. The client is considered expert in their own life and takes on expert status within 
the therapeutic relationship. The assumption is that the client will have the resources and skills they 
need to resolve the problem; rather than offer advice, the therapist’s role is to ask questions and 
listen in such a way that the client notices their own strengths and can formulate their own way of 
moving forwards. Acknowledgement of distress, including recognition of the impact of the stroke 
and aphasia, is also part of the therapy process in this study. The strongest evidence for the 
effectiveness of SFBT is in treating depression [22]. Further, there is a growing evidence base for its 
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effectiveness in managing chronic ill-health, for example, managing fatigue in Crohn’s disease [23] 
and coping with HIV/AIDS [24].  
A proof-of-concept study exploring SFBT with five people who had mild to moderate post-stroke 
aphasia reported encouraging trends in terms of improved mood and communicative participation 
and a main theme from the qualitative interviews was increased confidence [25]. The current study 
extends this preliminary work in a feasibility trial with the aim of informing the design and feasibility 
of a full-scale definitive trial. Following consultation work with people with aphasia the project 
focuses on living with stroke and aphasia in the longer term. We are therefore recruiting participants 
at least six months post stroke. 
Aims 
The aim of the study is to assess the feasibility of conducting a future definitive trial investigating the 
clinical and cost effectiveness of Solution Focused Brief Therapy for people living with chronic post-
stroke aphasia. Primary objectives of the trial are to evaluate the acceptability of the intervention to 
participants with varying severity and presentation of aphasia as well to the trial clinicians; the 
feasibility of recruitment and retention; the acceptability of research procedures; and the feasibility 
of delivering the intervention by Speech and language therapists. Secondary objectives are to 
evaluate the appropriateness of outcome measures; estimate a sample size for the definitive trial; 
and assess processes for evaluating treatment fidelity and documenting usual care. 
Methods 
Design 
This study is a single-blind, randomised, wait-list controlled feasibility trial comparing Solution 
Focused Brief Therapy plus usual care to usual care alone for people living with chronic post-stroke 
aphasia. All participants complete baseline assessment and are then randomised either to receive 
the intervention immediately or after a delay of six months. Both groups complete assessments at 
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three months and six months post randomisation; the wait-list group are also assessed nine months 
post randomisation. All participants are also invited to take part in in-depth interviews six months 
post randomisation in order to explore their experiences of taking part in the study; the wait-list 
group take part in an additional in-depth interview nine months post randomisation. Figure 1 
illustrates the flow of participants throughout the study. 
### insert Figure 1 about here ### 
The Consolidated Standards of Reporting Trials (CONSORT) 2010 extension statement to randomised 
pilot and feasibility trials [26] informed the study design. The Standard Protocol Items: 
Recommendations for Interventional Trials (SPIRIT) 2013 statement [27] guided the writing of the 
study protocol. The Template for Intervention Description and Replication (TIDieR) [28] informed the 
description of the intervention (see Table 1).  
Ethical approval 
Ethical approval to conduct the study was granted by the NHS Health Research Authority Brighton 
and Sussex Research Ethics Committee (17/LO/1255). Local NHS Research and Development 
approvals have also been gained from participating sites. The trial sponsor is City, University of 
London (Staff/17-18/04), and the study is funded by the Stroke Association (TSA Postdoc 2016/01). 
Participants 
Setting 
Participants will be identified through two National Health Service (NHS) community Speech and 
Language Therapy services, in East and West London, United Kingdom. We will also recruit via non-
NHS community routes, for example, through working with the voluntary sector. All visits will be 
conducted in the venue of the participant’s choice, anticipated to be either the participant’s home or 
the university clinic.  
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Participants: inclusion and exclusion criteria 
Participants will have a diagnosis of ischaemic or haemorrhagic stroke, be at least six months post 
stroke, 18 years old or over, and presenting with aphasia. Presence of aphasia will be determined by 
the clinical judgement of a Speech and language therapist. Participants will be excluded if they: have 
other diagnoses affecting cognition such as dementia or advanced Parkinson’s Disease; have severe 
uncorrected visual or hearing problems; have severe or potentially terminal co-morbidity; are 
currently receiving a psychological or psychiatric intervention from a mental health professional; 
were non-fluent English speakers prior to the stroke (based on self or family report); or do not have 
mental capacity to consent to take part. We are including people with any severity of aphasia, 
providing they have capacity. Use of anti-depressants or rehabilitation therapy will be recorded but 
will not be a reason for exclusion.  
Recruitment and consent processes 
The clinical care teams at the two participating NHS sites will screen people on their caseloads 
against the eligibility criteria before discussing the study with potential participants during a routine 
therapy or review appointment using a one-page summary information sheet. Where a person is 
potentially interested in taking part the clinician will ask permission to pass their contact details to 
the chief investigator (SN) who will then arrange to meet them to discuss the project further.  
Methods of community recruitment are diverse to allow comparison of different strategies. They 
include: visiting stroke and aphasia groups; accepting self-referrals (e.g. where a potential 
participant has learnt about the project from the funder’s website, twitter, project blog or word of 
mouth); distributing information about the project to third sector organisations; contacting people 
known to the University who have given permission for their details to be shared for this purpose. 
For those participants recruited via the community we will check they meet the eligibility criteria 
through asking a series of questions and relying on self-report. 
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Written informed consent will be obtained from all participants who are able to give it. For 
participants who are physically unable to sign the form an independent witness will sign on their 
behalf. All information sheets and consent forms have been developed using standard aphasia-
accessible principles (e.g. presenting one idea at a time, using short simple sentences, presenting key 
ideas with a suitable pictorial image). They have been based on templates created by the National 
Institute for Health Research [29] and informed by observations made by the SOFIA Aphasia 
Advisory Group. The chief investigator (SN), who is an experienced speech and language therapist, 
will meet with all potential participants to go through the participant information sheet and facilitate 
the person with aphasia discussing and asking questions about the project. Potential participants will 
receive the participant information sheet at least 24 hours in advance of this meeting. A person’s 
capacity to give informed consent will be made by SN, both informally and through asking three 
simple yes/no or forced alternative questions to confirm whether they have understood key aspects 
of the study.  
Participants may withdraw consent to participate in the study at any time and without giving a 
reason although we will record the reason if known. They may also elect to discontinue with the 
intervention but continue in the trial in which case we will seek permission to collect outcome data 
and carry out in-depth interviews with them.  
Randomisation 
The King’s Clinical Trials Unit will provide the randomisation service. After the baseline assessment 
visit has been completed the chief investigator will access the allocation for each participant by 
logging into the remote, secure internet-based randomisation system. Participants will be 
randomised in equal proportions to either the intervention group or the wait-list group. 
Randomisation allocation will use minimisation with a random component to avoid predictability of 
allocation. Minimisation will be based on two factors: site (two NHS trusts, community) and aphasia 
severity. Aphasia severity will be determined according to participants’ scores on the Frenchay 
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Aphasia Screening Test [30]: if a participant scores <7 on either the receptive or expressive domains 
during baseline assessment they will be classified as having severe aphasia.  
Blinding 
Participants, trial clinicians, the qualitative researcher, and the chief investigator will be aware of 
group allocation.  However, the research assistants who conduct the psychosocial outcome 
assessments will be blinded to group allocation. To reduce the likelihood of research assistants 
becoming unblinded we will request that participants do not reveal their group allocation during 
assessment visits (both prior to the visit and at the start of the visit); visits will be organised by the 
chief investigator; and research assistants will have no access to participant files or details that could 
potentially unblind them. If a researcher becomes unblinded this will be reported and any 
subsequent visits will be carried out by a different research assistant. Near misses will also be 
reported. The final visit for the wait-list group (nine months post randomisation) will be conducted 
by a research assistant blinded to both group allocation and time point.  A log will be kept of all 
instances of unblinding and near misses, as well as the reason for the unblinding.  
Intervention 
The intervention, therapist training and approach to measuring intervention fidelity are described 
using the TIDieR checklist (see Table 1) [28]. The wait-list group will receive the same intervention six 
months post randomisation. Both groups will additionally receive all usual care, including health 
care, social care and voluntary services. Usual care will be recorded for both groups at six months 
post randomisation. The choice of study design and comparator was influenced by the SOFIA 
Aphasia Advisory Group who considered acceptability to potential participants.  
### insert Table 1 about here ### 
Outcomes 
Trial data will be reported and presented according to the CONSORT 2010 statement: extension to 
randomised pilot and feasibility trials [26]. A CONSORT diagram of recruitment and participation will 
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be used as shown in Figure 2. We will report participant characteristics, as well as proportion of 
participants receiving rehabilitation therapy or anti-depressants, overall and by trial arm. 
### insert Figure 2 about here ### 
As a feasibility study the main endpoints relate to feasibility objectives. We outline four primary and 
four secondary endpoints. We also state pre-specified criteria for three of the four primary 
endpoints to guide the decision as to whether to proceed to a future definitive trial: the extent to 
which these thresholds have been met will be considered in conjunction with qualitative evidence. 
The pre-specified criteria are based on published trials investigating complex behavioural 
interventions with people with aphasia [16, 31] or stroke [32, 33]: reported recruitment, retention 
and adherence rates have informed what we consider to be realistic progression criteria. We will 
consider data from all time points including nine months post randomisation as appropriate. Clinical 
and economic evaluation outcome measures are listed in Table 2. 
Primary endpoints.  
[1] Acceptability of the intervention to participants and trial clinicians: evaluation based on rates of 
adherence to intervention where participants considered to have adhered if they elect to receive at 
least two therapy sessions; in-depth interviews with participants and trial clinicians; qualitative 
evaluation of trial clinicians’ therapy records e.g. clinician comments on acceptability; scores on the 
Session Rating Scale [34] assessing therapeutic alliance. Pre-specified criterion 1: proportion of 
participants who adhere (receive at least two therapy sessions) at least 80%.  
[2] Feasibility of recruitment and retention to the trial: evaluation based on proportion who give 
permission for their clinical care team to pass on contact details to the central research team; the 
proportion who consent; the rate of participants randomised each month; attrition rates (overall, by 
stage and by study arm) and reasons for attrition if known. Pre-specified criterion 2: proportion of 
eligible participants who consent at least 60%. Pre-specified criterion 3: proportion of participants 
who are followed up at 6 months post randomisation at least 70%. 
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[3] Acceptability of research procedures and outcome measures: evaluation based on participant 
interviews exploring their experience of study procedures; drop-out rates; rates of missing data. Pre-
specified criterion 4: proportion of missing data (per scale for all scales other than the Depression 
Intensity Scale Circles, DISCS) less than 15% for participants with mild to moderate receptive 
aphasia, defined as scoring ≥7 on the receptive domains of the Frenchay Aphasia Screening Test 
(FAST). Pre-specified criterion 5: proportion of all participants, including those with severe receptive 
aphasia, able to complete DISCS at least 90%.  
[4] Feasibility of delivering the intervention by experienced speech and language therapists: 
evaluation based on interviews with trial clinicians at end of the study and qualitative evaluation of 
the clinical supervisor’s records of clinical supervision sessions. In addition, the process of assessing 
fidelity will provide further insight into the extent to which speech and language therapists were 
able to deliver the intervention as intended. 
Secondary endpoints. 
[5] Appropriateness of outcome measures: evaluation based on level of variability of scores; missing 
data; floor or ceiling effects; whether scale constructs match any changes described during in-depth 
interviews; participant perspective on acceptability.  
[6] Estimating sample size: based on means and standard deviation of proposed primary clinical 
outcome measure (Warwick Edinburgh Mental Well-Being Scale, [35]) and retention rates. 
[7] Assessing treatment fidelity processes: evaluation based on acceptability of fidelity checking 
processes to trial clinicians and participants; utility and reliability of the fidelity check-list; and extent 
to which treatment is delivered as intended (i.e. compliant with the therapy manual). 
[8] Feasibility of documenting usual care and resource use: evaluation based on the acceptability and 
completeness of data generated by the adapted version of the Client Service Receipt Inventory 
(CSRI) [36]. 
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##insert Table 2 about here ## 
Patient reported outcome measures 
Primary and secondary outcomes: The primary clinical outcome in a future trial is likely to be 
psychological well-being, measured using the Warwick Edinburgh Mental Well-being Scale 
(WEMWBS) [35]. Potential secondary clinical outcomes will likely measure mood (General Health 
Questionnaire-12 item version [37], and Depression Intensity Scale Circles [38]); and communicative 
participation (Communicative Participation Item Bank, [39]). These measures will be tested in the 
current trial, and will be completed in face-to-face interview format at baseline, and at three and six 
months post randomisation, with additional visit nine months post randomisation for the wait-list 
group. The presentation of measures will be modified to make them accessible to people with 
aphasia in line with best practice [40]: participants will be able to read items as well as hear them; 
few items will be presented per page; a large font will be used; and participants will be able to point 
to their preferred response option. Practice items will be introduced for each scale to ensure 
participants understand the response formats. The content of the measures will not be changed to 
avoid affecting their psychometric properties. The visits will be conducted by research assistants 
who are qualified speech and language therapists able to facilitate responses of people with aphasia 
as appropriate. The measures chosen have all been successfully used with people with aphasia in 
previous research projects [25, 41]. The research assistants will receive initial training in completing 
the outcome measures as well as ongoing support to ensure consistency of approach. 
Profiling and co-variate measures: the Frenchay Aphasia Screening Test [30] will be conducted at 
baseline. Further, a measure of therapeutic alliance, the Session Rating Scale [34], will be completed 
during the in-depth interview by an unblinded researcher.  
Economic evaluation measures: participants will complete the EQ-5D-5L [42] measure at baseline, 
and all subsequent post-randomisation assessment points. An adapted version of the Client Service 
Receipt Inventory (CSRI) [36] will be collected by an unblinded research assistant at six months post 
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randomisation, capturing data for the previous 3 months. Modifications have been made to the CSRI 
so that it is more relevant and accessible to people with aphasia. 
Sample size 
We will recruit 32 participants, 16 participants allocated to each arm. This is line with 
recommendations which suggest a sample size of between 24 and 50 for a feasibility study [43-45]. 
This is considered sufficient to estimate the parameters of a larger trial, such as recruitment rates, 
consent rates, completion rates and standard deviation of outcome measures, with acceptable 
precision. We anticipate at least 24 participants will be followed up at 6 months, the likely endpoint 
in a future definitive trial. Effect sizes gained from the 6 month data point will be used to inform the 
sample size calculations of the future definitive trial. A recent aphasia therapy feasibility trial with a 
similar sample size (n=34) generated sufficiently useful information to enable progression to the 
definitive Big Cactus trial [31, 46]. In addition to collecting quantitative data, we are also inviting all 
participants to take part in in-depth interviews. Assuming at least 24 participants complete post 
therapy interviews, we anticipate this sample will enable us to capture a diverse range of 
perspectives into how the intervention has been experienced by this client group [47].  
Data management and monitoring 
The trial databases will be hosted at City, University of London, on a password-protected secure 
network drive accessed only by named personnel. The datasets will be anonymised with participants 
being identified by their unique Participant Identification Number. Data will be entered by 
authorised staff (SN and research assistants) with a full audit trail. Internal auditing of the data 
collected will occur throughout the trial. Data will be monitored for completeness and accuracy, with 
range and logic checks conducted and a random selection of at least 20% of the data double 
checked. The Chief investigator (SN) will meet with four senior academic supervisors every month 
throughout the project. This Academic Supervisory Group will monitor the progress of the trial 
including recruitment and adherence to protocol, as well as participant safety. In addition, a Trial 
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Steering Committee (TSC) will meet three times over the course of the trial to monitor study 
progress, adverse events, and advise on continuing or stopping the trial. As this is a small low-risk 
trial, the TSC will also take on the role of a Data Monitoring Committee. There are no planned 
interim analyses. The decision to stop the trial early on grounds of safety or futility will be made by 
the TSC, for example, if we fail to recruit, or have very low adherence rates. Any significant 
amendments to the protocol will be communicated to all relevant authorities including the TSC, the 
sponsor, the funder, the Health Research Authority, and the relevant trial registry. 
Analyses 
Quantitative analysis 
As a feasibility study the main endpoints relate to the feasibility objectives listed above. Descriptive 
statistics will be calculated for feasibility outcomes, along with 95% confidence intervals as 
appropriate. 
In terms of clinical outcomes, descriptive statistics will be presented for the primary clinical outcome 
measure of psychological well-being (WEMWBS) and three secondary outcomes (mood, GHQ-12, 
DISCS; and participation, CPIB). We will present the GHQ-12 data both as an overall score (range: 0 
to 12); and also as categorical data (participants scoring <3 classified as having no or low distress). 
These measures will be summarised using summary statistics measuring central tendency and 
dispersion, for the entire trial population and by trial arm, at each time point, including nine months 
post randomisation for the wait-list group. Means and confidence intervals will be plotted over time. 
Summary statistics will also be presented for the co-variate outcomes measuring aphasia severity 
(FAST) and therapeutic alliance (SRS).  
Since the intervention is therapist led, we will estimate the intra cluster correlation coefficient (ICC) 
for participants treated by the same therapist for outcomes six months post randomisation using a 
random effects model. In addition, we will report on appropriate effect sizes, along with associated 
95% confidence intervals, for the clinical outcomes. We will use a random effects model which 
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adjusts for therapist effect and also includes the baseline outcome as a covariate. We will use this 
data to estimate the sample size for the definitive trial.  
One of the aims of the trial is to explore the acceptability of the intervention and measures for 
people with severe aphasia (for this trial classified as scoring as <7 on either expressive or receptive 
domains of the FAST). As secondary analysis, we will additionally present the data for people with 
severe aphasia separately from people with mild to moderate aphasia for all outcome measures: any 
noteworthy differences between these two groups will be reported descriptively as group size is 
small.  
We will also conduct missing values analysis at the item level, scale level, and per administration as 
well as report the number of participants who have complete data for each time point, by treatment 
group and overall. The aim will be to build a picture of the characteristics of participants with 
missing data. The nature of the missing data will inform our evaluation of the acceptability of the 
different measures for this client group.  
Qualitative analysis 
Qualitative data will be reported according to the Standards for Reporting Qualitative Research 
Guidelines (SRQR) [48]. The primary source of data will be the in-depth interviews with participants 
and therapists, although we will also refer to therapy and supervision records. All interviews will be 
recorded with consent and transcribed verbatim. Data will be analysed using Framework Analysis 
[49] where raw data is tagged using a thematic index and is then synthesised into thematic matrices 
enabling between and within case analyses.  
Health economics analysis 
We will present the relevant costs and health outcomes for both the intervention group and the 
control group. For the costs, we will use data collected from the adapted CSRI at 6 months post 
randomisation: it will capture data from the previous 3 months. Costs will be derived from 
identifying resources used in terms of health and social care service use, intervention costs, as well 
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as informal care costs and costs to the individual. Unit costs of resources used will be derived from 
routine sources locally where possible and from national sources such as the NHS reference costs. 
We will use the relevant annual costing manual corresponding to the date when the resource use 
data was collected. We will also refer to the unit costs for health and social care compiled by the 
Personal Social Services Research Unit [50].  
Health gains will be obtained from WEMWBS and the EQ-5D-5L. These measures will inform two 
types of exploratory economic evaluation analysis, to ascertain the potential cost per unit of change 
in quality of life using each of the WEMWBS and EQ-5D-5L measures. Additionally, we will provide an 
estimate of the relative cost-effectiveness of care received in the intervention group compared to 
the wait-list control group: this is intended to inform the design of the economic analysis in a larger 
trial and will be exploratory in nature. We will examine the completeness of the data. We will also 
explore the acceptability and potential burden of the economic measures to people with aphasia 
and their family members, for example, in terms of time taken to complete. 
Service user involvement 
When developing the funding proposal we held a workshop with people who had post-stroke 
aphasia, both mild and severe, as well as a carer. This workshop influenced the choice of control 
group, the decision to target people at least six months post stroke, and to include people who had 
severe aphasia in the trial. In setting up and monitoring the current trial the SOFIA Aphasia Advisory 
Group is meeting eight times. The group is made up of four people with aphasia and one family 
member, including two people who have experience of receiving the intervention. The group has 
already provided advice on: the design of project information including the participant information 
sheet; recruitment process; presentation of outcome measures; topic guide for the in-depth 
interviews; ideas to improve the accessibility of the therapy approach; and ways to enhance the 
participant experience. They have additionally contributed to therapist training. In future meetings 
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they will advise on issues in the trial as they arise; discuss interpreting findings and dissemination; 
and consider ways to build a community around the project. 
Adverse events, ancillary care and post-trial care 
This study is exploring a non-physical non-invasive intervention. As such, adverse events related to 
participating in the study are considered unlikely. Research assistants and trial clinicians will report 
all adverse events, both related and unrelated to the study, to the chief investigator. For the 
purposes of this trial, a participant scoring >3 on the GHQ-12, indicative of moderate psychological 
distress, is considered an adverse event. In this case, the research assistant will follow a set protocol. 
They will seek permission for the chief investigator to share the results with their primary care 
physician (General Practitioner, GP). They will also advise the participant to visit their GP and 
facilitate this visit as required. The participant will be given the choice as to whether to remain in the 
project. If a research assistant or trial clinician has serious concerns about a participant’s mental or 
physical well-being a decision will be made with the participant and other relevant authorities about 
what is in their best interests, for example, escalation of psychological care and potentially 
withdrawal from the study. 
In terms of ancillary care, all research assistants and trial clinicians are also qualified Speech and 
language therapists who will receive additional training for the trial from the chief investigator, as 
well as ongoing support. They will be able to listen to participant concerns and will be trained to 
respond appropriately to participant distress. They will also receive training on the core values of the 
project which prioritise a positive participant experience during all research visits e.g. participants 
should feel valued and respected when collecting outcome data; research assistants are encouraged 
to take an interest in participants as people.  In addition, information about local support sources 
will be offered if participants express feelings of loneliness or low mood. All participants have met 
the chief investigator during the initial information giving visit. The SOFIA Aphasia Advisory Group 
advised that the potential participant should be listened to holistically during this visit and that the 
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process should feel two way. Participants and their families are given the chief investigator’s direct 
work phone line and email address and are encouraged to contact the chief investigator if they have 
concerns.  Further, it is the chief investigator who communicates their group allocation and is in 
contact with them throughout the trial to confirm or arrange follow up visits, providing continuity. 
Where possible, we also organise that it is the same research assistant who conducts the first three 
assessment visits. Participants will not receive any financial incentives to take part in the trial. 
In terms of post-trial support, the final visit for all participants is an in-depth interview with a 
researcher unblinded to treatment allocation and aware of how they have progressed through the 
trial (e.g. with access to their therapy records and outcome data). This researcher is well placed to 
talk through different options going forward (e.g. discuss voluntary organisations that offer support 
and other opportunities within the university), as well as thank them for their contribution and let 
them know what to expect next. 
Dissemination policy 
The results of the study will be reported and disseminated at academic and clinical conferences and 
in peer-reviewed scientific journals, as well as to our funder and the two NHS sites. Our SOFIA 
Aphasia Advisory Group will advise on how best to disseminate the results to the public and stroke 
community, for example, writing in the newsletters of stroke and aphasia voluntary organisations, 
attending stroke events or via social media.  We will also work with the SOFIA Aphasia Advisory 
Group to create an aphasia-accessible results leaflet to explain the results to participants and others 
involved in the trial, as well as holding a dissemination event. 
Study status 
The recruitment was scheduled to take 13 months, from 31st October 2017 until 30th November 
2018. Recruitment began two weeks earlier than planned on 17th October 2017, and was completed 
on 5th November 2019. Data collection has not yet been completed and the study is ongoing.  
 
SOFIA protocol paper v2 17Oct2018 Page 21 of 33 
 
Discussion 
This study will evaluate the feasibility of conducting a definitive randomised controlled trial 
evaluating clinical and cost effectiveness of Solution Focused Brief Therapy for people living with 
chronic post-stroke aphasia. The aim of the therapy is to enhance the psychological well-being of 
people with aphasia.  
The current study may provide valuable information on ways to adapt a psychological talk-based 
therapy so that it is accessible to people with a communication difficulty. We decided to include 
people with severe aphasia. There is evidence that people with severe aphasia have significantly 
lower health-related quality of life than people with mild to moderate aphasia [51]; have three-fold 
worse activity limitations in communication than those with moderate aphasia [52]; and are at high 
risk of social exclusion [53]. Preliminary evidence from a pilot study linked to the current trial 
suggested that it was possible to modify the approach to make it communicatively accessible to 
people with severe aphasia, and that they found the therapy approach acceptable [54]. The SOFIA 
study will provide further information on whether there are particular presentations of aphasia 
which make the approach less acceptable. A potential challenge of including people with more 
severe aphasia is exploring how best to capture any change. We took the decision to collect data 
directly from participants rather than rely on proxy responses, as there are is some evidence that 
that proxy responses are not commensurable with self-report, particularly for less observable, more 
subjective constructs. Proxies tend to score people with aphasia as more severely affected than the 
people with aphasia scores themselves [55, 56]. We have carefully selected measures which have 
been used successfully with people with aphasia in previous studies, and will monitor closely 
whether people with more severe aphasia are able to self-report on all the chosen measures in 
order to inform our choice of measures in the definitive trial. 
In conclusion, this study will assist in building the evidence base for potential effective interventions 
for a client group excluded from most stroke research exploring psychological interventions. The 
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study may also provide useful information on the viability of speech and language therapists 
delivering a psychological intervention, including their perspective on support and training needs. 
Finally, the intervention and the therapist training are both relatively brief suggesting that the 
approach has the potential to be integrated into routine clinical practice.  
This paper reports on protocol version 2 (date: 24th August 2017).  
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Table 1. SOFIA Trial: Template for Intervention Description and Replication (TIDieR) checklist 
Item Description 
1: Name SOlution Focused Brief Therapy In post-stroke Aphasia (SOFIA Trial) 
2: Rationale, 
theory or goal 
of the 
intervention 
The aim of the intervention is to enhance psychological well-being. Solution Focused 
Brief Therapy (SFBT) hypothesises that in enabling a client to describe their 
preferred future, as well as notice their competencies, skills, and instances of 
success, the client can be supported in building positive change [20, 57]. 
3: Materials 
for training 
and delivery 
A therapy manual has been developed to guide the training and supervision of trial 
clinicians, as well as the delivery of the intervention. The manual describes the basic 
tenets of Solution Focused Brief Therapy, drawing on established descriptions of the 
approach, for example, provided by the United Kingdom Association for Solution 
Focused Practice. It follows the model of Solution Focused Brief Therapy developed 
by Evans, Iveson and Ratner [20]. Trial clinicians will receive a copy of the manual as 
well as additional resources such as PowerPoint slides and checklists.  
No specific materials are required for the delivery of the intervention. However, to 
ensure that the intervention is accessible to people with more severe aphasia, 
therapists will use pictorial resources including those developed by Talking Mats ©. 
In addition, therapists will use paper and pen to facilitate total communication, for 
example, drawing pictures, diagrams or scales, or writing down key words. They will 
also use objects in the environment and be responsive to modes of communication 
and materials preferred by the participant e.g. use of paper diary or iPad.  
4: The 
Intervention: 
Procedures, 
activities, 
processes 
 
SFBT is a talk-based psychological intervention. It explores how a person would like 
their life to be and their hopes for the future. It also seeks to enable people to notice 
their own resources, resilience, and what is already working. As the participant is 
considered expert in their own lives, the therapist refrains from offering advice, 
solutions or strategies, and instead seeks to facilitate the client in finding their own 
way forward.  
Key assumptions:  
It is anticipated that the therapist will hold in mind certain key assumptions 
throughout the therapy process. These include: the participant is expert in their own 
lives thus will direct the shape of the therapy sessions; that all participants have 
resources, talents, competencies and strengths, and the therapist’s job is to enable 
the participant to notice them; that a ‘solution’ may be brought about by small 
steps, hence a focus on noticing the everyday details of a person’s life; that the 
therapist will hear and validate the participant’s stories sufficiently to create a 
context where change can occur. 
Key behaviours:  
Two behaviours are expected to be present in all sessions: use of the client’s words 
and frames of reference to guide therapist utterances; and the therapist facilitating 
the communication of the person with aphasia so that they can participate fully in 
the intervention. 
Other key behaviours anticipated to be present in some sessions include: 
establishing what the participant is hoping for from the therapy; eliciting preferred 
future descriptions (enabling a participant to describe the everyday details of their 
life if they achieved their therapy goals); inviting the participant to notice what is 
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already working and instances of success, for example, through listing what they’ve 
been pleased to notice or using scaling questions; eliciting descriptions of 
interactional sequences and the perspectives of other people in the participant’s 
life; problem-free talk (noticing the person and what’s important to them, what 
gives them joy); and acknowledgement of the stroke, aphasia, recovery and distress.   
5: 
Intervention 
providers 
The intervention is provided by speech and language therapists with experience of 
working with people with aphasia. The trial clinicians receive four days ‘foundation 
training’ in the core principles and practices of Solution Focused Brief Therapy at the 
Brief Centre for Solution Focused Practice, London. They additionally receive two 
days training at City, University of London (led by SN), which focus on adapting the 
approach for people with aphasia, study procedures, and developing their skills 
through feedback from members of the SOFIA Aphasia Advisory Group. In addition, 
they receive training in how to respond to distress and escalate psychological care 
appropriately (led by mental health nurses, AS and CF). Finally, they receive monthly 
clinical supervision provided by a speech and language therapist who is also an 
expert in SFBT. 
6: Mode of 
delivery 
 
The intervention is delivered face to face and provided individually rather than in a 
group setting. Participants can choose whether to include family members or friends 
within the therapy sessions.  
7: Location 
 
Participants can choose the location of therapy sessions. It is anticipated this will 
mostly be their own home or the University Clinic. Seeing people in their own home 
will mean we can include more isolated and housebound participants.  
8: When and 
how much 
 
Participants will be offered up to six sessions spaced over 3 months. The scheduling 
and number of sessions is led by the participant. Each session will be approximately 
one hour long. Although SFBT is typically brief (3-5 sessions [20]) people with 
aphasia are likely to need additional sessions, as less material can be covered in 
each session due to the language disability [25].  
9. Tailoring 
 
The content of SFBT sessions is individualised for each participant. Within any 
specific session, therapist utterances follow from what the participant says: as such, 
there is an inherent flexibility. Nonetheless, it is expected that there will be 
consistency across all sessions in terms of the underlying assumptions that underpin 
therapist utterances and key therapist behaviours (see Item 4).  
The sessions are also individualised to enable people with varying presentations of 
aphasia to participate. It is likely that not all aspects of the approach will be feasible 
for people with more severe aphasia (e.g. detailed description of the preferred 
future or describing extended interactional sequences). As such, it is anticipated that 
for some participants sessions will focus on aspects of the approach less dependent 
on complex linguistic structures (e.g. celebrating recent successes using photos on 
the participant’s phone).  
10: 
Modifications  
If any modifications are made to the intervention during the project they will be 
reported in full. 
11: Adherence 
and fidelity 
(planned) 
Adherence:  
Adherence is defined as receiving at least two therapy sessions. We will report on 
the number of sessions participants choose to receive, how they elect to space the 
sessions, and any complicating factors reported (e.g. sessions cancelled due to 
participant or therapist illness). We will also analyse participant and therapist views 
on dosage and spacing of therapy during the in-depth interviews. 
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Fidelity:  
A fidelity checklist has been developed listing the core assumptions expected to be 
present in therapy sessions, as well as key observable behaviours. Clinicians will self-
rate using the checklist after each session. They will bring the completed checklists 
to clinical supervision for discussion. It is intended that the reflective process of 
completing the checklist will enhance the likelihood that the intervention is being 
delivered as intended. It is also anticipated that fidelity will be enhanced by regular 
clinical supervision with an expert in the SFBT approach. 
 
Additionally, a proportion of sessions (at least 15%) will be either audio or video 
recorded with participant consent. Each therapist will record a diverse sample of 
sessions including: initial, middle and final sessions; and sessions recorded at all 
stages of the project (i.e. when therapists are less experienced near the beginning of 
the trial; mid-trial; and near the end of the trial). The recordings will then be rated 
by independent raters using the fidelity checklist to determine the extent to which 
the intervention was delivered as intended. 
12: Adherence 
and fidelity 
(actual) 
Adherence and fidelity results will be reported at the end of trial. 
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Table 2: Outcome measures used in SOFIA study 
Outcome measure Construct Modifications made for 
SOFIA Trial 
Clinical Outcomes   
Warwick Edinburgh 
Mental Wellbeing Scale 
(WEMWBS) [35] 
Mental wellbeing Presentation, not content, 
adjusted to be more accessible 
to people with aphasia. 
General Health 
Questionnaire – 12 item 
version (GHQ) [37] 
Psychological Distress Presentation, not content, 
adjusted to be more accessible 
to people with aphasia. 
Depression Intensity 
Scale Circles (DISCS) [38] 
Depression Presentation, not content, 
adjusted to be more accessible 
to people with aphasia. 
Communicative 
Participation Item Bank 
(CPIB) [39] 
Communicative Participation Presentation, not content, 
adjusted to be more accessible 
to people with aphasia. 
Profiling and co-variate   
Frenchay Aphasia 
Screening Test (FAST) 
[30] 
Language  No modifications 
Session Rating Scale (SRS) 
[34] 
Therapeutic alliance Author of SRS has created two 
versions. Linguistically simpler 
version used. 
Economic Evaluation   
European Quality of Life, 
5 Dimension, 5 Levels 
(EQ-5D-5L) [42] 
Health-related quality of life Presentation, not content, 
adjusted to be more accessible 
to people with aphasia. 
Adapted Client Service 
Receipt Inventory (CSRI) 
[36] 
Service and resource use Modifications made to both 
presentation and content so as 
to be more relevant and 
accessible to people with 
aphasia. 
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Figure 1: SOFIA Trial Flowchart  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Randomisation (Time 0): participant data entered into online randomisation system which allocates 
study group (1:1 ratio) 
Initial contact, information giving and consent processes 
Potential participants interested in the study sent the Participant Information Sheet; chief investigator 
meets them to discuss the project and, where appropriate, obtain informed consent. 
Baseline  
Assessment visit: Participants complete FAST, DISCS, WEMWBS, GHQ-12, CPIB, EQ-5D-5L 
Identification of potential participants 
People with post-stroke aphasia identified via: [1] NHS clinical staff from current and past patient 
records (initial information given about project; for those potentially interested consent sought to pass 
on contact details to research team); or [2] community (e.g. stroke groups, advertising). Eligibility 
assessed by referring clinician or via self-report with chief investigator. 
3 months post randomisation 
Assessment visit: Participants complete DISCS, WEMWBS, GHQ-12, CPIB, EQ-5D-5L  
6 months post randomisation 
Assessment visit: Participants complete DISCS, WEMWBS, GHQ-12, CPIB, EQ-5D-5L 
Interview visit: Participants take part in in-depth interview and also complete Session Rating Scale 
(SRS). Participants also asked to complete adapted Client Service Receipt Inventory (CSRI): for some 
this may mean an additional visit. 
 
Intervention  
Receive up to six SFBT sessions plus all usual care 
Wait-list control 
Receive all usual care 
 
Wait-list control only 
Receive up to six SFBT sessions 
 
9 months post randomisation 
Assessment visit: Wait-list control only 
Participants complete DISCS, WEMWBS, GHQ-
12, CPIB, EQ-5D-5L 
Interview visit: In-depth interview including SRS 
 
 
 
    
 
Key  
DISCS: Depression Intensity Scale Circles; CPIB: Communicative Participation Item Bank; CSRI: Client Service 
Receipt Inventory; EQ-5D-5L: European Quality of Life – 5 Dimensions, 5 Levels; FAST: Frenchay Aphasia 
Screening Test; GHQ-12: General Health Questionnaire 12 item version; SRS: Session Rating Scale; WEMWBS: 
Warwick Edinburgh Mental Wellbeing Scale 
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Figure 2: SOFIA CONSORT flow diagram 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
NHS sites: patients with stroke 
and aphasia screened for eligibility 
against medical records 
(n=xx) 
Did not give consent for 
contact details to be passed 
on to research team (n=xx) 
• Reasons (n=xx) 
Approached for consent 
(n=xx) 
Excluded (n=xx) 
• Reasons (n=xx) 
Baseline assessments 
0 weeks (n=xx) 
Randomised  
(n=xx) 
Allocated to intervention (n=xx) Allocated to wait-list (n=xx) 
3-month follow up  
Completed follow up (n=xx)  
Did not complete follow up (n=xx) 
• Reasons if known (n=xx) 
 
6-month follow up  
Completed follow up (n=xx)  
Did not complete follow up (n=xx) 
• Reasons if known (n=xx) 
 
3-month follow up  
Completed follow up (n=xx)  
Did not complete follow up (n=xx) 
• Reasons if known (n=xx) 
  
     
 6-month follow up 
Completed follow up (n=xx)  
Did not complete follow up (n=xx) 
• Reasons if known (n=xx) 
 
Wait-list intervention (n=xx) 
Received intervention (at least 2 
sessions) (n=xx)  
Did not receive intervention (n=xx) 
• Reasons if known (n=xx) 
 
Excluded (n=xx) 
• Reasons (n=xx) 
NHS sites: eligible patients asked 
for consent to pass on details to 
research team 
(n=xx) 
Community: people with aphasia 
express an interest in the study, 
e.g. after hearing about study at 
stroke group or from advert 
(n=xx) 
 
Patient not eligible (n=xx) 
• Reasons (n=xx) 
Community: patient not 
eligible (eligibility 
confirmed through self-
report) 
(n=xx) 
• Reasons (n=xx) 
 
Immediate intervention (n=xx) 
Received intervention (at least 2 
sessions) (n=xx)  
Did not receive intervention (n=xx) 
• Reasons if known (n=xx) 
 
9-month follow up 
Completed follow up (n=xx)  
Did not complete follow up (n=xx) 
• Reasons if known (n=xx) 
 
